LEXICON PHARMACEUTICALS, INC. Treasury Stock, Common, Shares
LEXICON PHARMACEUTICALS, INC. (LXRX) had Treasury Stock, Common, Shares of 1.93 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-08-06
- 2026-06-30: Treasury Stock, Common, Shares 1.93M shares.
- 2026-03-31: Treasury Stock, Common, Shares 1.93M shares.
- 2025-12-31: Treasury Stock, Common, Shares 2.38M shares.
- 2025-09-30: Treasury Stock, Common, Shares 2.38M shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-06-30 | 1.93M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 1.93M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 2.38M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 2.38M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 2.38M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 2.38M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 1.53M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 1.53M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 1.53M shares 10-Q · filed 2024-08-02 |
| 2024-03-31 | 1.53M shares 10-Q · filed 2024-05-02 |
| 2023-12-31 | 867.97K shares 10-K · filed 2025-03-07 |
| 2023-09-30 | 867.97K shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 867.97K shares 10-Q · filed 2023-08-04 |
| 2022-12-31 | 488.20K shares 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |